TreeWAS – Variant ID: rs2071303

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E83.1 Disorders of iron metabolism	0.000	0.000	1.000
K90.0 Coeliac disease	1.000	0.000	0.000
K90 Intestinal malabsorption	0.741	0.259	0.000
K90.4 Malabsorption due to intolerance, not elsewhere classified	0.688	0.312	0.000
K90.8 Other intestinal malabsorption	0.539	0.461	0.000
K90.3 Pancreatic steatorrhoea	0.532	0.468	0.000
K90.2 Blind loop syndrome, not elsewhere classified	0.532	0.468	0.000
K90.1 Tropical sprue	0.532	0.468	0.000
K90.9 Intestinal malabsorption, unspecified	0.494	0.506	0.000
I10 Essential (primary) hypertension	0.221	0.779	0.000
K90-K93 Other diseases of the digestive system	0.108	0.892	0.000
K93 Disorders of other digestive organs in diseases classified elsewhere	0.078	0.922	0.000
K91 Postprocedural disorders of digestive system, not elsewhere classified	0.070	0.930	0.000
K91.9 Postprocedural disorder of digestive system, unspecified	0.059	0.941	0.000
K91.0 Vomiting following gastro-intestinal surgery	0.059	0.941	0.000
K93.8 Disorders of other specified digestive organs in diseases classified elsewhere	0.056	0.944	0.000
K93.1 Megacolon in Chagas' disease	0.056	0.944	0.000
K93.0 Tuberculous disorders of intestines, peritoneum and mesenteric glands	0.056	0.944	0.000
K91.2 Postsurgical malabsorption, not elsewhere classified	0.054	0.946	0.000
K91.8 Other postprocedural disorders of digestive system, not elsewhere classified	0.053	0.947	0.000
E83 Disorders of mineral metabolism	0.000	0.954	0.046
K91.1 Postgastric surgery syndromes	0.042	0.958	0.000
I10-I15 Hypertensive diseases	0.042	0.958	0.000
K91.5 Postcholecystectomy syndrome	0.042	0.958	0.000
K91.4 Colostomy and enterostomy malfunction	0.041	0.959	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.960	0.040
Z87.4 Personal history of diseases of the genito-urinary system	0.000	0.961	0.039
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.036	0.964	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.034	0.966	0.000
C82.2 Large cell, follicular	0.034	0.966	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.966	0.034
E83.9 Disorder of mineral metabolism, unspecified	0.000	0.967	0.033
E83.8 Other disorders of mineral metabolism	0.000	0.967	0.033
E83.2 Disorders of zinc metabolism	0.000	0.967	0.033
E83.0 Disorders of copper metabolism	0.000	0.967	0.033
C81 Hodgkin's disease	0.033	0.967	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.032	0.968	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.031	0.969	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.969	0.031
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.031	0.969	0.000
C81.9 Hodgkin's disease, unspecified	0.031	0.969	0.000
I13 Hypertensive heart and renal disease	0.030	0.969	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.030	0.970	0.000
T42.4 Benzodiazepines	0.000	0.970	0.030
I15 Secondary hypertension	0.030	0.970	0.000
C81.1 Nodular sclerosis	0.030	0.970	0.000
C85.1 B-cell lymphoma, unspecified	0.029	0.971	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.028	0.972	0.000
C81.0 Lymphocytic predominance	0.028	0.972	0.000
C81.2 Mixed cellularity	0.027	0.973	0.000
C82.0 Small cleaved cell, follicular	0.027	0.973	0.000
I11 Hypertensive heart disease	0.026	0.974	0.000
C82.6 Cutaneous follicle centre lymphoma	0.026	0.974	0.000
C82.5 Diffuse follicle centre lymphoma	0.026	0.974	0.000
C82.4 Follicular lymphoma grade IIIb	0.026	0.974	0.000
T42.1 Iminostilbenes	0.000	0.974	0.026
C84 Peripheral and cutaneous T-cell lymphomas	0.025	0.975	0.000
I15.1 Hypertension secondary to other renal disorders	0.025	0.975	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.975	0.025
E83.3 Disorders of phosphorus metabolism	0.000	0.975	0.025
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.976	0.024
T42.2 Succinimides and oxazolidinediones	0.000	0.976	0.024
K91.3 Postoperative intestinal obstruction	0.024	0.976	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.024	0.976	0.000
C81.3 Lymphocytic depletion	0.024	0.976	0.000
T42.0 Hydantoin derivatives	0.000	0.977	0.023
I15.8 Other secondary hypertension	0.023	0.977	0.000
C85.0 Lymphosarcoma	0.023	0.977	0.000
C93 Monocytic leukaemia	0.023	0.977	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.023	0.977	0.000
C94 Other leukaemias of specified cell type	0.023	0.977	0.000
J84.1 Other interstitial pulmonary diseases with fibrosis	0.022	0.978	0.000
I13.9 Hypertensive heart and renal disease, unspecified	0.022	0.978	0.000
I13.2 Hypertensive heart and renal disease with both (congestive) heart failure and renal failure	0.022	0.978	0.000
I13.1 Hypertensive heart and renal disease with renal failure	0.022	0.978	0.000
I13.0 Hypertensive heart and renal disease with (congestive) heart failure	0.022	0.978	0.000
C84.5 Other and unspecified T-cell lymphomas	0.022	0.978	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.022	0.978	0.000
I15.2 Hypertension secondary to endocrine disorders	0.022	0.978	0.000
I15.0 Renovascular hypertension	0.022	0.978	0.000
I11.0 Hypertensive heart disease with (congestive) heart failure	0.021	0.979	0.000
C82.3 Follicular lymphoma grade IIIa	0.021	0.979	0.000
C88 Malignant immunoproliferative diseases	0.021	0.979	0.000
C81.7 Other Hodgkin's disease	0.021	0.979	0.000
C86 Other specified types of T/NK-cell lymphoma	0.021	0.979	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.021	0.979	0.000
C95 Leukaemia of unspecified cell type	0.021	0.979	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.020	0.980	0.000
T42.3 Barbiturates	0.000	0.981	0.019
C84.9 Mature T/NK-cell lymphoma, unspecified	0.018	0.981	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.018	0.981	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.018	0.981	0.000
C84.3 Lymphoepithelioid lymphoma	0.018	0.981	0.000
C84.2 T-zone lymphoma	0.018	0.981	0.000
C84.1 Sezary's diease	0.018	0.981	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.018	0.982	0.000
C92 Myeloid leukaemia	0.018	0.982	0.000
C84.0 Mycosis fungoides	0.018	0.982	0.000
C91 Lymphoid leukaemia	0.017	0.983	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.017	0.983	0.000
C93.1 Chronic monocytic leukaemia	0.017	0.983	0.000
C93.9 Monocytic leukaemia, unspecified	0.016	0.983	0.000
C93.7 Other monocytic leukaemia	0.016	0.983	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.016	0.983	0.000
C93.2 Subacute monocytic leukaemia	0.016	0.983	0.000
C93.0 Acute monocytic leukaemia	0.016	0.983	0.000
C94.7 Other specified leukaemias	0.016	0.983	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.016	0.983	0.000
C94.5 Acute myelofibrosis	0.016	0.983	0.000
C94.4 Acute panmyelosis	0.016	0.983	0.000
C94.3 Mast cell leukaemia	0.016	0.983	0.000
C94.2 Acute megakaryoblastic leukaemia	0.016	0.983	0.000
C94.1 Chronic erythraemia	0.016	0.983	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.016	0.983	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.016	0.983	0.000
C96.8 Histiocytic sarcoma	0.016	0.983	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.016	0.983	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.016	0.983	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.016	0.983	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.016	0.983	0.000
C96.3 True histiocytic lymphoma	0.016	0.983	0.000
C96.2 Malignant mast cell tumour	0.016	0.983	0.000
C96.1 Malignant histiocytosis	0.016	0.983	0.000
C96.0 Letterer-Siwe disease	0.016	0.983	0.000
I12 Hypertensive renal disease	0.016	0.984	0.000
C83.3 Large cell (diffuse)	0.016	0.984	0.000
D37.4 Colon	0.000	0.984	0.016
C88.9 Malignant immunoproliferative disease, unspecified	0.015	0.984	0.000
C88.7 Other malignant immunoproliferative diseases	0.015	0.984	0.000
C88.3 Immunoproliferative small intestinal disease	0.015	0.984	0.000
C88.2 Gamma heavy chain disease	0.015	0.984	0.000
C88.1 Alpha heavy chain disease	0.015	0.984	0.000
C95.0 Acute leukaemia of unspecified cell type	0.015	0.985	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.015	0.985	0.000
C86.4 Blastic NK-cell lymphoma	0.015	0.985	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.015	0.985	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.015	0.985	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.015	0.985	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.015	0.985	0.000
C95.7 Other leukaemia of unspecified cell type	0.015	0.985	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.015	0.985	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.015	0.985	0.000
C91.0 Acute lymphoblastic leukaemia	0.015	0.985	0.000
C84.4 Peripheral T-cell lymphoma	0.014	0.985	0.000
C92.5 Acute myelomonocytic leukaemia	0.014	0.986	0.000
I15.9 Seconday hypertension, unspecified	0.014	0.986	0.000
D12.2 Ascending colon	0.000	0.986	0.014
J84 Other interstitial pulmonary diseases	0.014	0.986	0.000
C83.1 Small cleaved cell (diffuse)	0.014	0.986	0.000
C83.5 Lymphoblastic (diffuse)	0.014	0.986	0.000
C92.0 Acute myeloid leukaemia	0.014	0.986	0.000
C92.9 Myeloid leukaemia, unspecified	0.014	0.986	0.000
C83.6 Undifferentiated (diffuse)	0.013	0.986	0.000
C83.4 Immunoblastic (diffuse)	0.013	0.986	0.000
C83.2 Mixed small and large cell (diffuse)	0.013	0.986	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.013	0.987	0.000
D37.5 Rectum	0.000	0.987	0.013
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.013	0.987	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.013	0.987	0.000
C92.3 Myeloid sarcoma	0.013	0.987	0.000
C92.2 Subacute myeloid leukaemia	0.013	0.987	0.000
C91.5 Adult T-cell leukaemia	0.013	0.987	0.000
C92.4 Acute promyelocytic leukaemia	0.013	0.987	0.000
C95.9 Leukaemia, unspecified	0.013	0.987	0.000
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs	0.000	0.987	0.013
C83.7 Burkitt's tumour	0.013	0.987	0.000
C91.9 Lymphoid leukaemia, unspecified	0.013	0.987	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.012	0.988	0.000
C91.7 Other lymphoid leukaemia	0.012	0.988	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.012	0.988	0.000
C91.3 Prolymphocytic leukaemia	0.012	0.988	0.000
C91.2 Subacute lymphocytic leukaemia	0.012	0.988	0.000
J84.0 Alveolar and parietoalveolar conditions	0.012	0.988	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.012	0.988	0.000
C83.0 Small cell (diffuse)	0.012	0.988	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.011	0.988	0.000
D37.2 Small intestine	0.000	0.989	0.011
J84.9 Interstitial pulmonary disease, unspecified	0.011	0.989	0.000
D37.6 Liver, gallbladder and bile ducts	0.000	0.989	0.010
C92.7 Other myeloid leukaemia	0.010	0.990	0.000
D37.0 Lip, oral cavity and pharynx	0.000	0.990	0.010
I11.9 Hypertensive heart disease without (congestive) heart failure	0.010	0.990	0.000
E83.4 Disorders of magnesium metabolism	0.000	0.990	0.010
O44.1 Placenta praevia with haemorrhage	0.010	0.990	0.000
U80.1 Methicillin resistant agent	0.010	0.990	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.010	0.990	0.000
D37.1 Stomach	0.000	0.990	0.010
I12.9 Hypertensive renal disease without renal failure	0.009	0.991	0.000
D37.9 Digestive organ, unspecified	0.000	0.991	0.009
J84.8 Other specified interstitial pulmonary diseases	0.009	0.991	0.000
I27.2 Other secondary pulmonary hypertension	0.009	0.991	0.000
M41.99 Scoliosis, unspecified (Site unspecified)	0.000	0.992	0.008
C92.1 Chronic myeloid leukaemia	0.008	0.992	0.000
C91.4 Hairy-cell leukaemia	0.008	0.992	0.000
I27 Other pulmonary heart diseases	0.008	0.992	0.000
G58.9 Mononeuropathy, unspecified	0.008	0.992	0.000
D86.9 Sarcoidosis, unspecified	0.008	0.992	0.000
I27.9 Pulmonary heart disease, unspecified	0.008	0.992	0.000
B02.9 Zoster without complication	0.008	0.992	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.007	0.992	0.000
I46.9 Cardiac arrest, unspecified	0.008	0.992	0.000
D37.7 Other digestive organs	0.000	0.992	0.008
I27.0 Primary pulmonary hypertension	0.008	0.992	0.000
J86.9 Pyothorax without fistula	0.007	0.993	0.000
D37.3 Appendix	0.000	0.993	0.007
C90.1 Plasma cell leukaemia	0.007	0.993	0.000
K10.2 Inflammatory conditions of jaws	0.000	0.993	0.007
D86 Sarcoidosis	0.007	0.993	0.000
M41.95 Scoliosis, unspecified (Thoracolumbar region)	0.000	0.993	0.007
D86.3 Sarcoidosis of skin	0.007	0.993	0.000
K92 Other diseases of digestive system	0.007	0.993	0.000
M41.9 Scoliosis, unspecified	0.000	0.993	0.007
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.994	0.006
J99.8 Respiratory disorders in other diseases classified elsewhere	0.006	0.994	0.000
S72.40 Fracture of lower end of femur (closed)	0.006	0.994	0.000
C90.2 Plasmacytoma, extramedullary	0.006	0.994	0.000
B02 Zoster [herpes zoster]	0.006	0.994	0.000
C50.2 Upper-inner quadrant of breast	0.006	0.994	0.000
D86.1 Sarcoidosis of lymph nodes	0.006	0.994	0.000
L52 Erythema nodosum	0.006	0.994	0.000
I27.1 Kyphoscoliotic heart disease	0.006	0.994	0.000
I27.8 Other specified pulmonary heart diseases	0.006	0.994	0.000
K92.8 Other specified diseases of digestive system	0.006	0.994	0.000
C90.3 Solitary plasmacytoma	0.006	0.994	0.000
J92.0 Pleural plaque with presence of asbestos	0.006	0.994	0.000
M41.97 Scoliosis, unspecified (Lumbosacral region)	0.000	0.994	0.005
D86.8 Sarcoidosis of other and combined sites	0.005	0.994	0.000
D86.0 Sarcoidosis of lung	0.005	0.994	0.000
T81.3 Disruption of operation wound, not elsewhere classified	0.005	0.995	0.000
J86 Pyothorax	0.005	0.995	0.000
B02.8 Zoster with other complications	0.005	0.995	0.000
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes	0.005	0.995	0.000
K10.8 Other specified diseases of jaws	0.000	0.995	0.005
J80-J84 Other respiratory diseases principally affecting the interstitium	0.005	0.995	0.000
M41.90 Scoliosis, unspecified (Multiple sites in spine)	0.000	0.995	0.005
K10 Other diseases of jaws	0.000	0.995	0.005
N20.1 Calculus of ureter	0.000	0.995	0.005
J35.1 Hypertrophy of tonsils	0.000	0.995	0.005
M41.98 Scoliosis, unspecified (Sacral and sacrococcygeal region)	0.000	0.995	0.005
M41.93 Scoliosis, unspecified (Cervicothoracic region)	0.000	0.995	0.005
M41.92 Scoliosis, unspecified (Cervical region)	0.000	0.995	0.005
M41.91 Scoliosis, unspecified (Occipito-atlanto-axial region)	0.000	0.995	0.005
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.995	0.005
J99 Respiratory disorders in diseases classified elsewhere	0.005	0.995	0.000
E14.9 Without complications	0.005	0.995	0.000
B01.9 Varicella without complications	0.005	0.995	0.000
B02.2 Zoster with other nervous system involvement	0.005	0.995	0.000
M41.94 Scoliosis, unspecified (Thoracic region)	0.000	0.995	0.005
B02.7 Disseminated zoster	0.005	0.995	0.000
B02.1 Zoster meningitis	0.005	0.995	0.000
B02.0 Zoster encephalitis	0.005	0.995	0.000
D12 Benign neoplasm of colon, rectum, anus and anal canal	0.000	0.995	0.005
D12.1 Appendix	0.000	0.995	0.005
J82 Pulmonary eosinophilia, not elsewhere classified	0.005	0.995	0.000
B01 Varicella [chickenpox]	0.004	0.995	0.000
J92 Pleural plaque	0.005	0.995	0.000
B00-B09 Viral infections characterized by skin and mucous membrane lesions	0.004	0.996	0.000
D12.0 Caecum	0.000	0.996	0.004
J92.9 Pleural plaque without asbestos	0.004	0.996	0.000
D12.4 Descending colon	0.000	0.996	0.004
J86.0 Pyothorax with fistula	0.004	0.996	0.000
O44 Placenta praevia	0.004	0.996	0.000
J98.0 Diseases of bronchus, not elsewhere classified	0.004	0.996	0.000
B02.3 Zoster ocular disease	0.004	0.996	0.000
E27.4 Other and unspecified adrenocortical insufficiency	0.004	0.996	0.000
S61.8 Open wound of other parts of wrist and hand	0.004	0.996	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.996	0.004
T39.1 4-Aminophenol derivatives	0.000	0.996	0.004
J95-J99 Other diseases of the respiratory system	0.004	0.996	0.000
E16.2 Hypoglycaemia, unspecified	0.004	0.996	0.000
K10.3 Alveolitis of jaws	0.000	0.996	0.004
B00 Herpesviral [herpes simplex] infections	0.004	0.996	0.000
J98 Other respiratory disorders	0.004	0.996	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.996	0.004
K10.1 Giant cell granuloma, central	0.000	0.996	0.004
U80 Agent resistant to penicillin and related antibiotics	0.004	0.996	0.000
B44.1 Other pulmonary aspergillosis	0.004	0.996	0.000
K10.9 Disease of jaws, unspecified	0.000	0.996	0.004
T50.4 Drugs affecting uric acid metabolism	0.000	0.996	0.004
B00.9 Herpesviral infection, unspecified	0.004	0.996	0.000
T50.8 Diagnostic agents	0.000	0.996	0.004
T50.7 Analeptics and opioid receptor antagonists	0.000	0.996	0.004
T50.5 Appetite depressants	0.000	0.996	0.004
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.996	0.004
T50.1 Loop [high-ceiling] diuretics	0.000	0.996	0.004
T50.0 Mineralocorticoids and their antagonists	0.000	0.996	0.004
J99.1 Respiratory disorders in other diffuse connective tissue disorders	0.004	0.996	0.000
K10.0 Developmental disorders of jaws	0.000	0.996	0.004
J98.2 Interstitial emphysema	0.004	0.996	0.000
J98.6 Disorders of diaphragm	0.004	0.996	0.000
B00.5 Herpesviral ocular disease	0.004	0.996	0.000
B44.9 Aspergillosis, unspecified	0.004	0.996	0.000
O36.9 Maternal care for foetal problem, unspecified	0.004	0.996	0.000
L50.1 Idiopathic urticaria	0.004	0.996	0.000
D12.9 Anus and anal canal	0.000	0.996	0.004
D12.6 Colon, unspecified	0.000	0.996	0.004
L50.0 Allergic urticaria	0.004	0.996	0.000
L50 Urticaria	0.004	0.996	0.000
J98.4 Other disorders of lung	0.004	0.996	0.000
Z88.1 Personal history of allergy to other antibiotic agents	0.000	0.996	0.004
I46 Cardiac arrest	0.004	0.996	0.000
B01.8 Varicella with other complications	0.003	0.996	0.000
B01.2 Varicella pneumonia	0.003	0.996	0.000
B01.1 Varicella encephalitis	0.003	0.996	0.000
B01.0 Varicella meningitis	0.003	0.996	0.000
B00.8 Other forms of herpesviral infection	0.003	0.996	0.000
E14 Unspecified diabetes mellitus	0.004	0.996	0.000
B08 Other viral infections characterised by skin and mucous membrane lesions, not elsewhere classified	0.003	0.996	0.000
B06 Rubella [German measles]	0.003	0.997	0.000
B05 Measles	0.003	0.997	0.000
B09 Unspecified viral infection characterised by skin and mucous membrane lesions	0.003	0.997	0.000
B04 Monkeypox	0.003	0.997	0.000
B03 Smallpox	0.003	0.997	0.000
B44 Aspergillosis	0.003	0.997	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.997	0.003
E85.4 Organ-limited amyloidosis	0.000	0.997	0.003
O46.9 Antepartum haemorrhage, unspecified	0.003	0.997	0.000
L92.9 Granulomatous disorder of skin and subcutaneous tissue, unspecified	0.003	0.997	0.000
L50-L54 Urticaria and erythema	0.003	0.997	0.000
J95 Postprocedural respiratory disorders, not elsewhere classified	0.003	0.997	0.000
B00.3 Herpesviral meningitis	0.003	0.997	0.000
E14.3 With ophthalmic complications	0.003	0.997	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.997	0.003
J85-J86 Suppurative and necrotic conditions of lower respiratory tract	0.003	0.997	0.000
J99.0 Rheumatoid lung disease	0.003	0.997	0.000
E27.1 Primary adrenocortical insufficiency	0.003	0.997	0.000
I46.1 Sudden cardiac death, so described	0.003	0.997	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.997	0.003
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.997	0.003
F40.2 Specific (isolated) phobias	0.000	0.997	0.003
E14.5 With peripheral circulatory complications	0.003	0.997	0.000
J96 Respiratory failure, not elsewhere classified	0.003	0.997	0.000
C91.1 Chronic lymphocytic leukaemia	0.003	0.997	0.000
J81 Pulmonary oedema	0.003	0.997	0.000
J95.9 Postprocedural respiratory disorder, unspecified	0.003	0.997	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.997	0.003
B00.7 Disseminated herpesviral disease	0.003	0.997	0.000
B00.0 Eczema herpeticum	0.003	0.997	0.000
E05.9 Thyrotoxicosis, unspecified	0.003	0.997	0.000
J98.3 Compensatory emphysema	0.003	0.997	0.000
E85.9 Amyloidosis, unspecified	0.000	0.997	0.003
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.997	0.003
D12.7 Rectosigmoid junction	0.000	0.997	0.003
J95.0 Tracheostomy malfunction	0.003	0.997	0.000
U80.8 Agent resistant to other penicillin-related antibiotic	0.003	0.997	0.000
T36 Poisoning by systemic antibiotics	0.000	0.997	0.003
E14.1 With ketoacidosis	0.003	0.997	0.000
B00.4 Herpesviral encephalitis	0.003	0.997	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.997	0.003
B37.9 Candidiasis, unspecified	0.003	0.997	0.000
E85 Amyloidosis	0.000	0.997	0.003
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.997	0.003
S72.4 Fracture of lower end of femur	0.003	0.997	0.000
J98.5 Diseases of mediastinum, not elsewhere classified	0.003	0.997	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.997	0.003
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.997	0.003
B37.1 Pulmonary candidiasis	0.003	0.997	0.000
C90.0 Multiple myeloma	0.003	0.997	0.000
Z22.3 Carrier of other specified bacterial diseases	0.003	0.997	0.000
M84.48 Pathological fracture, not elsewhere classified (Other)	0.000	0.997	0.003
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.997	0.003
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.997	0.003
S06.40 Epidural haemorrhage (without open intracranial wound)	0.000	0.997	0.003
M86.97 Osteomyelitis, unspecified (Ankle and foot)	0.003	0.997	0.000
E14.6 With other specified complications	0.003	0.997	0.000
N75.0 Cyst of Bartholin's gland	0.000	0.997	0.003
M41 Scoliosis	0.000	0.997	0.003
M46.92 Inflammatory spondylopathy, unspecified (Cervical region)	0.000	0.997	0.003
L50.6 Contact urticaria	0.003	0.997	0.000
L50.5 Cholinergic urticaria	0.003	0.997	0.000
L50.4 Vibratory urticaria	0.003	0.997	0.000
L50.3 Dermatographic urticaria	0.003	0.997	0.000
L50.2 Urticaria due to cold and heat	0.003	0.997	0.000
N40 Hyperplasia of prostate	0.000	0.997	0.003
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.997	0.003
E27 Other disorders of adrenal gland	0.003	0.997	0.000
N20 Calculus of kidney and ureter	0.000	0.997	0.003
E85.3 Secondary systemic amyloidosis	0.000	0.997	0.003
J45.0 Predominantly allergic asthma	0.000	0.997	0.003
L51 Erythema multiforme	0.003	0.997	0.000
E14.7 With multiple complications	0.003	0.997	0.000
E14.0 With coma	0.003	0.997	0.000
B05.9 Measles without complication	0.003	0.997	0.000
B05.8 Measles with other complications	0.003	0.997	0.000
B05.4 Measles with intestinal complications	0.003	0.997	0.000
B05.3 Measles complicated by otitis media	0.003	0.997	0.000
B05.2 Measles complicated by pneumonia	0.003	0.997	0.000
B05.1 Measles complicated by meningitis	0.003	0.997	0.000
B05.0 Measles complicated by encephalitis	0.003	0.997	0.000
B06.9 Rubella without complication	0.003	0.997	0.000
B06.8 Rubella with other complications	0.003	0.997	0.000
B06.0 Rubella with neurological complications	0.003	0.997	0.000
B08.8 Other specified viral infections characterised by skin and mucous membrane lesions	0.003	0.997	0.000
B08.5 Enteroviral vesicular pharyngitis	0.003	0.997	0.000
B08.4 Enteroviral vesicular stomatitis with exanthem	0.003	0.997	0.000
B08.3 Erythema infectiosum [fifth disease]	0.003	0.997	0.000
B08.2 Exanthema subitum [sixth disease]	0.003	0.997	0.000
B08.0 Other orthopoxvirus infections	0.003	0.997	0.000
B44.8 Other forms of aspergillosis	0.003	0.997	0.000
B44.7 Disseminated aspergillosis	0.003	0.997	0.000
B44.2 Tonsillar aspergillosis	0.003	0.997	0.000
B44.0 Invasive pulmonary aspergillosis	0.003	0.997	0.000
T39.4 Antirheumatics, not elsewhere classified	0.000	0.997	0.003
T39.2 Pyrazolone derivatives	0.000	0.997	0.003
B08.1 Molluscum contagiosum	0.003	0.997	0.000
N20.0 Calculus of kidney	0.000	0.997	0.003
E16 Other disorders of pancreatic internal secretion	0.003	0.997	0.000
O46 Antepartum haemorrhage, not elsewhere classified	0.003	0.997	0.000
L50.9 Urticaria, unspecified	0.003	0.997	0.000
L54 Erythema in diseases classified elsewhere	0.003	0.997	0.000
S32.50 Fracture of pubis (closed)	0.000	0.997	0.003
J95.5 Postprocedural subglottic stenosis	0.003	0.997	0.000
J95.4 Mendelson's syndrome	0.003	0.997	0.000
J95.3 Chronic pulmonary insufficiency following surgery	0.003	0.997	0.000
J95.2 Acute pulmonary insufficiency following nonthoracic surgery	0.003	0.997	0.000
J95.1 Acute pulmonary insufficiency following thoracic surgery	0.003	0.997	0.000
L51.9 Erythema multiforme, unspecified	0.003	0.997	0.000
E83.5 Disorders of calcium metabolism	0.000	0.997	0.003
T45.2 Vitamins, not elsewhere classified	0.000	0.997	0.003
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.997	0.003
E14.8 With unspecified complications	0.003	0.997	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.997	0.003
I12.0 Hypertensive renal disease with renal failure	0.003	0.997	0.000
K92.9 Disease of digestive system, unspecified	0.003	0.997	0.000
O36.4 Maternal care for intra-uterine death	0.003	0.997	0.000
T41.5 Therapeutic gases	0.000	0.997	0.002
T41.4 Anaesthetic, unspecified	0.000	0.997	0.002
T41.3 Local anaesthetics	0.000	0.997	0.002
T41.2 Other and unspecified general anaesthetics	0.000	0.997	0.002
T41.1 Intravenous anaesthetics	0.000	0.997	0.002
T41.0 Inhaled anaesthetics	0.000	0.997	0.002
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.997	0.002
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.997	0.002
T46.7 Peripheral vasodilators	0.000	0.997	0.002
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.997	0.002
B07 Viral warts	0.003	0.997	0.000
J96.9 Respiratory failure, unspecified	0.002	0.997	0.000
J96.1 Chronic respiratory failure	0.002	0.997	0.000
J96.0 Acute respiratory failure	0.002	0.997	0.000
M65.34 Trigger finger-Hand	0.003	0.997	0.000
O44.0 Placenta praevia specified as without haemorrhage	0.002	0.997	0.000
Z90.3 Acquired absence of part of stomach	0.003	0.997	0.000
J85 Abscess of lung and mediastinum	0.002	0.997	0.000
B00.2 Herpesviral gingivostomatitis and pharyngotonsillitis	0.002	0.997	0.000
B37.4 Candidiasis of other urogenital sites	0.002	0.997	0.000
E14.2 Withrenal complications	0.002	0.997	0.000
J98.9 Respiratory disorder, unspecified	0.002	0.997	0.000
T38.1 Thyroid hormones and substitutes	0.000	0.997	0.002
Y49.2 Other and unspecified antidepressants	0.000	0.997	0.003
O46.8 Other antepartum haemorrhage	0.002	0.997	0.000
J35.8 Other chronic diseases of tonsils and adenoids	0.000	0.997	0.002
T36.9 Systemic antibiotic, unspecified	0.000	0.997	0.002
T36.8 Other systemic antibiotics	0.000	0.997	0.002
T36.7 Antifungal antibiotics, systemically used	0.000	0.997	0.002
T36.6 Rifamycins	0.000	0.997	0.002
T36.5 Aminoglycosides	0.000	0.997	0.002
T36.3 Macrolides	0.000	0.997	0.002
T36.2 Chloramphenicol group	0.000	0.997	0.002
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.997	0.002
S72.41 Fracture of lower end of femur (open)	0.002	0.998	0.000
D12.8 Rectum	0.000	0.998	0.002
T36.0 Penicillins	0.000	0.998	0.002
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.998	0.002
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.998	0.002
T49.9 Topical agent, unspecified	0.000	0.998	0.002
T49.8 Other topical agents	0.000	0.998	0.002
T49.7 Dental drugs, topically applied	0.000	0.998	0.002
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.998	0.002
T49.5 Ophthalmological drugs and preparations	0.000	0.998	0.002
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.998	0.002
T49.3 Emollients, demulcents and protectants	0.000	0.998	0.002
T49.2 Local astringents and local detergents	0.000	0.998	0.002
T49.1 Antipruritics	0.000	0.998	0.002
B37 Candidiasis	0.002	0.998	0.000
E85.8 Other amyloidosis	0.000	0.998	0.002
E85.2 Heredofamilial amyloidosis, unspecified	0.000	0.998	0.002
E85.1 Neuropathic heredofamilial amyloidosis	0.000	0.998	0.002
E85.0 Nonneuropathic heredofamilial amyloidosis	0.000	0.998	0.002
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.998	0.002
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.998	0.002
T48.4 Expectorants	0.000	0.998	0.002
T48.3 Antitussives	0.000	0.998	0.002
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.998	0.002
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.998	0.002
T48.0 Oxytocic drugs	0.000	0.998	0.002
M48.54 Collapsed vertebra, not elsewhere classified (Thoracic region)	0.000	0.998	0.002
T45.5 Anticoagulants	0.000	0.998	0.002
T38.9 Other and unspecified hormone antagonists	0.000	0.998	0.002
T38.7 Androgens and anabolic congeners	0.000	0.998	0.002
T38.5 Other oestrogens and progestogens	0.000	0.998	0.002
T38.4 Oral contraceptives	0.000	0.998	0.002
T38.2 Antithyroid drugs	0.000	0.998	0.002
T38.0 Glucocorticoids and synthetic analogues	0.000	0.998	0.002
E14.4 With neurological complications	0.002	0.998	0.000
O73.0 Retained placenta, without haemorrhage	0.002	0.998	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.998	0.002
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.998	0.002
T45.8 Other primarily systemic and haematological agents	0.000	0.998	0.002
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.998	0.002
T45.6 Fibrinolysis-affecting drugs	0.000	0.998	0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations